BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16268664)

  • 1. Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders.
    Malone RP; Gratz SS; Delaney MA; Hyman SB
    CNS Drugs; 2005; 19(11):923-34. PubMed ID: 16268664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.
    Posey DJ; McDougle CJ
    Harv Rev Psychiatry; 2000; 8(2):45-63. PubMed ID: 10902094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of children and adolescents with pervasive developmental disorders.
    Hanft A; Hendren RL
    Essent Psychopharmacol; 2004; 6(1):12-24. PubMed ID: 15612651
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacotherapeutic management of autism.
    Posey DJ; McDougle CJ
    Expert Opin Pharmacother; 2001 Apr; 2(4):587-600. PubMed ID: 11336609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
    Findling RL
    J Clin Psychiatry; 2005; 66 Suppl 10():26-31. PubMed ID: 16401147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy in children and adolescents with pervasive developmental disorders.
    Scahill L; Koenig K
    J Child Adolesc Psychiatr Nurs; 1999; 12(1):41-3. PubMed ID: 10347430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacology of autistic spectrum disorders in children and adolescents.
    Nazeer A
    Pediatr Clin North Am; 2011 Feb; 58(1):85-97, x. PubMed ID: 21281850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism.
    Malone RP; Waheed A
    Drugs; 2009; 69(5):535-48. PubMed ID: 19368416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychopharmacology of autism spectrum disorders].
    Poustka L; Banaschewski T; Poustka F
    Nervenarzt; 2011 May; 82(5):582-9. PubMed ID: 21484169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form].
    Desjardins S; Doyen C; Contejean Y; Kaye K; Paubel P
    Encephale; 2009 Apr; 35(2):168-72. PubMed ID: 19393386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of aggression in children and adolescents with autism and conduct disorder.
    McDougle CJ; Stigler KA; Posey DJ
    J Clin Psychiatry; 2003; 64 Suppl 4():16-25. PubMed ID: 12672261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.
    Doyle CA; McDougle CJ
    Dialogues Clin Neurosci; 2012 Sep; 14(3):263-79. PubMed ID: 23226952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological treatments in patients with pervasive developmental disorders: A review].
    Béhérec L; Quilici G; Rosier A; Gerardin P; Campion D; Guillin O
    Encephale; 2014 Apr; 40(2):188-96. PubMed ID: 24369879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate an effective treatment for ADHD?
    McDougle CJ
    J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
    King BH; Hollander E; Sikich L; McCracken JT; Scahill L; Bregman JD; Donnelly CL; Anagnostou E; Dukes K; Sullivan L; Hirtz D; Wagner A; Ritz L;
    Arch Gen Psychiatry; 2009 Jun; 66(6):583-90. PubMed ID: 19487623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
    McDougle CJ; Holmes JP; Carlson DC; Pelton GH; Cohen DJ; Price LH
    Arch Gen Psychiatry; 1998 Jul; 55(7):633-41. PubMed ID: 9672054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
    Adler BA; Wink LK; Early M; Shaffer R; Minshawi N; McDougle CJ; Erickson CA
    Autism; 2015 Jan; 19(1):102-6. PubMed ID: 24571823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.